|
IQVIA™ Real-World Insights Bibliography
| Empagliflozin is Associated with Lower Risk of Cardiovascular Events and All-Cause Mortality in Routine Care in East Asia: Results from the EMPRISE Study
|
| Author(s): Dae Jung Kim (1), Wayne H-H Sheu (2), Wook-Jin Chung (3), Daisuke Yabe (4-7), Kyoung Hwa Ha (1), Masaomi Nangaku (8), Elise Chia-Hui Tan (9), Koichi Node (10), Atsutaka Yasui (11), Weiyu Lei (12), Sunwoo Lee (13), Laura Saarelainen (14), Anouk Deruaz-Luyet (15), Moe H. Kyaw (16) and Yutaka Seino (4,17), EMPRISE East Asia Study Group
|
| Affiliations(s): "1
Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea
2
Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan
3
Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea
4
Kansai Electric Power Medical Research Institute, Kobe, Japan
5
Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan
6
Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan
7
Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
8
Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan
9
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan, and Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan
10
Department of Cardiovascular Medicine, Saga University, Saga, Japan
11
Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan
12
Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan
13
Boehringer Ingelheim Korea Ltd, Seoul, Korea
14
IQVIA, Espoo, Finland
15
Boehringer Ingelheim International GmbH, Ingelheim, Germany
16
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
17
Kansai Electric Power Hospital, Osaka, Japan
" |
Publication(s): "JDI journal
Virtual Conference: ACC, May 2021"
|
| Document Type(s): Article, |
| Countries: Japan, Korea, Taiwan, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study,
2023 |
|
L:
A: |
English
Clinical setting: hospital, Clinical setting: Primary care, Retrospective cohort analysis, |
|
 |
| |
| |
| Cost-effectiveness analysis of ranibizumab biosimilar for neovascular age-related macular degeneration in Japan |
| Author(s): Yasuo Yanagi 1, Kanji Takahashi 2, Tomohiro Iida 3, Fumi Gomi 4, Junko Morii 5, Eriko Kunikane 6, Taiji Sakamoto 7 (rwesheorj 5) |
| Affiliations(s): 1 Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan. yanagi-tky@umin.ac.jp.
2 Department of Ophthalmology, Kansai Medical University, Osaka, Japan.
3 Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
4 Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan.
5 IQVIA Solutions Japan, K.K., Tokyo, Japan.
6 Senju Pharmaceutical Co., Ltd., Osaka, Japan.
7 Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. |
Publication(s): Ophthalmology and Therapy
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Vascular disease,
2023 |
|
L:
A: |
English
Cost analysis, Cost effectiveness, |
|
|
| |
| |
| Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review |
| Author(s): Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4) |
| Affiliations(s): 1 Graduate School of Economics, Nagoya City University, Nagoya, Japan.
2 Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com.
3 Health & Value, Pfizer Japan Inc., Tokyo, Japan.
4 IQVIA Solutions Japan K.K., Tokyo, Japan. |
Publication(s): Pharmaceutical Medicine
|
| Document Type(s): Article, |
| Countries: France, Germany, Japan, UK, USA, |
| Click here for the abstract |
C:
Y: |
Miscellaneous,
2023 |
|
L:
A: |
English
Literature Review, |
|
|
| |
| |
| Patient burden associated with treatment-resistant or unexplained chronic cough - a qualitative study based on focus group interviews |
| Author(s): Naoya Ueda 1, Anzu Yakushiji 2, Shigeru Tokita 1, Takekazu Kubo 1 (rwesheorj 2) |
| Affiliations(s): 1) MSD Co., Ltd., Medical Affairs
2) IQVIA Solutions Japan K.K., Tokyo, Japan |
Publication(s): Progress in Medicine
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2023 |
|
L:
A: |
Japanese
Burden of illness, Patient questionnaire, |
|
|
| |
| |
| Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements |
| Author(s): Masataka Kuwana 1, Masashi Bando 2, Yutaka Kawahito 3, Shinji Sato 4, Takafumi Suda 5, Yasuhiro Kondoh 6; CTD-ILD Delphi Collaborators (rwesheorj A) |
| Affiliations(s): 1) Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
2) Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.
3) Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
4) Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
5) Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
6) Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan. |
Publication(s): Expert Review of Respiratory Medicine
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2023 |
|
L:
A: |
English
Literature Review, Survey research, |
|
|
| |
| |
| Exploring current practice, knowledge, and challenges of sexually transmitted infection/HIV management and pre-exposure prophylaxis among Japanese health care professionals: a cross-sectional web survey |
| Author(s): Mayuko Kamakura 1, Daisuke Fukuda 1, Naho Kuroishi 1, Dilinuer Ainiwaer 2, Junko Hattori 1 (rwesheorj 2) |
| Affiliations(s): 1) Medical Affairs, MSD K.K., Tokyo, Japan
2) IQVIA Solutions Japan K.K., Tokyo, Japan |
Publication(s): AIDS Patient Care and STDs
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
HIV AIDS,
2023 |
|
L:
A: |
English
Survey research, |
|
|
| |
| |
| Comparison of depression trends in the Japanese and US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data |
| Author(s): Sven Demiya 1, Shujiro Takeno 1, Louis P. Watanabe 1, Wen Shi Lee 1, Yuri Sakai 1, Todd D. Taylor 1, Seok-Won Kim 1 (rwesheorj 1) |
| Affiliations(s): 1) IQVIA Solutions Japan KK, Tokyo Japan |
Publication(s): Value & Outcomes Spotlight
|
| Document Type(s): Article, |
| Countries: Japan, USA, |
| Click here for the abstract |
C:
Y: |
Mental health,
2023 |
|
L:
A: |
English
Database Study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| Cost of illness: estimating direct healthcare costs related to obesity in a Japanese clinical setting |
| Author(s): Riku Ota 1, Koki Idehara 2, Hiroyuki Matsuda 2, Ronald Filomeno 2, J Baker-Knight 3 (rwesheorj 2) |
| Affiliations(s): 1) Novo Nordisk Pharma Ltd., Nerima, 13, Japan
2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
3) Novo Nordisk, 2900, Denmark |
Publication(s): ISPOR
Value in Health
|
| Document Type(s): Abstract, Conference, Poster, Presentation, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Endocrinology,
2023 |
|
L:
A: |
English
Cost of illness, Database Study, |
|
|
| |
| |
| Real-world trends of patients with syphilis in Japan using integrated data of IQVIA Claims, JAST data and DeSC database |
| Author(s): Yuki Kado 1, Seok-Won Kim 2, T Ishii 3 (rwesheorj 1-3) |
| Affiliations(s): 1) IQVIA Solutions Japan, Minato-ku, 13, Japan
2) IQVIA Solutions Japan, Minato, 13, Japan
3) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan |
Publication(s): ISPOR
Value in Health
|
| Document Type(s): Abstract, Conference, Poster, Presentation, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Infectious disease,
2023 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
| Real-world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database |
| Author(s): Junichi Omura 1, Kazuki Kitahara 1, Masashi Takano 1, Koki Idehara 2, Seok-Won Kim 2 (rwesheorj 2) |
| Affiliations(s): 1) Medical Affairs Janssen Pharmaceutical K. K. Tokyo Japan
2) RWES/HEOR IQVIA Solutions Japan K. K. Tokyo Japan |
Publication(s): Pulmonary Circulation
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease,
2023 |
|
L:
A: |
English
Database Study, Retrospective cohort analysis, |
|
|
| |
| |
 1 of 8 
|
|
